MATERIALS AND METHODS FOR STRATIFYING AND TREATING CANCERS
作者： Lee Alex , Jones Robin , Huang Paul , Cheang Maggie
DOI:
关键词: Tyrosine kinase 、 PDGFRA 、 Tp53 mutation 、 Cancer 、 Gene expression 、 Medicine 、 Cancer research 、 Fibroblast growth factor receptor 1
摘要: The present invention relates to materials and methods for stratifying treating cancers of identifying/selecting patients treatment cancer with tyrosine kinase inhibitors. Gene expression profiles, TP53 mutations FGFR1 PDGFRA are used identify/select/stratify the patients.
lens.org 参考文章(7)
Yan Wang, Cynthia Seidel-Dugan, Yaolin Wang, Diane Levitan, Ming Liu, Wei Ding, Biomarkers for sensitivity to anti-igf1r therapy ,(2008)
Nisha Mohindra, Mark Agulnik, Targeted therapy and promising novel agents for the treatment of advanced soft tissue sarcomas. Expert Opinion on Investigational Drugs. ,vol. 24, pp. 1409- 1418 ,(2015) , 10.1517/13543784.2015.1076792
S Sleijfer, T Gorlia, C Lamers, H Burger, J-Y Blay, A Le Cesne, M Scurr, F Collin, L Pandite, S Marreaud, P Hohenberger, Cytokine and angiogenic factors associated with efficacy and toxicity of pazopanib in advanced soft-tissue sarcoma: an EORTC-STBSG study British Journal of Cancer. ,vol. 107, pp. 639- 645 ,(2012) , 10.1038/BJC.2012.328
T-M Kim, S-A Ha, H K Kim, J Yoo, S Kim, S-H Yim, S-H Jung, D-W Kim, Y-J Chung, J W Kim, Gene expression signatures associated with the in vitro resistance to two tyrosine kinase inhibitors, nilotinib and imatinib Blood Cancer Journal. ,vol. 1, pp. e32- e32 ,(2011) , 10.1038/BCJ.2011.32
Chun-Ming Tsai, Teh-Ying Chou, Method for evaluating the efficacy of an egfr-tki treatment ,(2015)
Joel Parker, Petros Giannikopoulos, John St. John, Trevor Bivona, Methods for Predicting EGFR Tyrosine Kinase Inhibitor Efficacy ,(2015)
Kihoon Cha, Yi Li, Gwan-Su Yi, Discovering gene expression signatures responding to tyrosine kinase inhibitor treatment in chronic myeloid leukemia BMC Medical Genomics. ,vol. 9, pp. 29- 29 ,(2016) , 10.1186/S12920-016-0194-5